Skip to main content
AMLX logo

AMLX · Amylyx Pharmaceuticals, Inc.

$18.50 +1.05 (+6.02%) At close · Jul 21
Market Cap
$2.06B
Shares
111.19M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 173
Total Value: $1,581,972,863
Total Shares: 113,782,056
Showing 1–100 of 182 holdings by value · page 1 of 2

Institutional Ownership Trend

18 quarters

Holder Concentration

Across 172 13F filers
Top Holder
14.6%
Jun 2023 → Mar 2026 · range 8.2% – 14.7%
of institutional value
Top 5
40.1%
Jun 2023 → Mar 2026 · range 27.6% – 40.7%
of institutional value
Top 10
57.9%
Jun 2023 → Mar 2026 · range 42.9% – 59.4%
of institutional value
HHI
499
Jun 2023 → Mar 2026 · range 281 – 510
Broadly held
Showing 100 of 182
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1658551 CUSIP 03237H101 13F (30d) 10 filings 10 filers Visit website Investor relations